Bafna Pharmaceuticals Limited (BAFNAPH) — Cash Flow Reinvestment Rate
Bafna Pharmaceuticals Limited (BAFNAPH) has a Cash Flow Reinvestment Rate of 1.76x as of September 2025, reinvesting Rs164.17 Million (capex Rs164.17 Million ) from operating cash flow of Rs93.12 Million. Check Bafna Pharmaceuticals Limited (BAFNAPH) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Bafna Pharmaceuticals Limited Cash Flow Reinvestment Rate (2007–2026)
Historical reinvestment intensity for Bafna Pharmaceuticals Limited across 10 annual periods. Explore BAFNAPH operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Bafna Pharmaceuticals Limited (2007–2026)
Year-by-year capital reinvestment analysis for Bafna Pharmaceuticals Limited. For live market cap and broader valuation context, see BAFNAPH market cap.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2026 | 2.11x | Rs249.03 Million | Rs118.27 Million | Rs249.03 Million | ▼ -4.4% |
| 2025 | 2.20x | Rs430.23 Million | Rs195.29 Million | Rs218.60 Million | ▼ -31.8% |
| 2024 | 3.23x | Rs306.32 Million | Rs94.85 Million | Rs155.78 Million | ▲ +1.8% |
| 2023 | 3.17x | Rs157.11 Million | Rs49.52 Million | Rs82.19 Million | ▲ +137.8% |
| 2022 | 1.33x | Rs129.80 Million | Rs97.28 Million | Rs75.41 Million | ▼ -47.3% |
| 2016 | 2.53x | Rs23.07 Million | Rs9.11 Million | Rs23.07 Million | ▲ +246.7% |
| 2015 | 0.73x | Rs77.90 Million | Rs106.65 Million | Rs77.90 Million | ▼ -33.1% |
| 2014 | 1.09x | Rs17.53 Million | Rs16.06 Million | Rs17.53 Million | ▲ +1778.7% |
| 2013 | 0.06x | Rs21.28 Million | Rs366.32 Million | Rs21.28 Million | ▼ -96.9% |
| 2007 | 1.85x | Rs187.01 Million | Rs101.06 Million | Rs187.01 Million | — |